I addition, a significantly lower expression of the NOTCH3 −exon 16 transcript was observed in GCB patients classified as vincristine resistant by the REGS classifier, supporting the BAGS classification of DLBCL, which predicted centroblasts to be more vincristine resistant8,9. Here, NOTCH3 is linked to diffuse large B-cell lymphoma.